Start
Entdecken
nav.journalClub
Trends
Mehr
synapse
⌘+K
Sprache
Deutsch
March 3, 2026
Impact of oral semaglutide on quality of life and metabolic parameters in patients with type 2 diabetes mellitus: A multicenter observational study
JG
Javier Lago Garma
University Hospital Complex Of Vigo
CM
Cristina Gil Mouce
Hospital Universitario Lucus Augusti
NN
Nazareth Rodríguez Novo
Hospital Universitario Lucus Augusti
See all
Key Points
Quality of life improved significantly among patients receiving oral semaglutide, indicating favorable treatment effects.
Patients showed notable enhancements in metabolic parameters, demonstrating the drug's efficacy beyond glycemic control.
Observational analysis across multiple centers assessed patient-reported outcomes and metabolic changes over a specific timeframe.
Findings suggest that oral semaglutide may enhance both well-being and physical health in those managing type 2 diabetes.
Mark Helpful
Like
Save
Bookmark
Relay
Share
Mark Helpful
Like
Save
Bookmark
Relay
Share
Cite This Study
Copy
Garma et al. (Sun,) studied this question.
synapsesocial.com/papers/69a767e5badf0bb9e87e2d00
https://doi.org/https://doi.org/10.1016/j.endien.2026.501713
Impact of oral semaglutide on quality of life and metabolic parameters in patients with type 2 diabetes mellitus: A multicenter observational study | Synapse